Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 67,209 |
| Other current assets | 1,235 |
| TOTAL | $68,444 |
| Non-Current Assets | |
| Other Non-Current Assets | 4,334 |
| TOTAL | $4,334 |
| Total Assets | $74,579 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 5,815 |
| Accrued Expenses | 19,437 |
| TOTAL | $25,967 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 240,086 |
| TOTAL | $240,086 |
| Total Liabilities | $266,865 |
| Shareholders' Equity | |
| Retained earnings | -193,279 |
| Other shareholders' equity | -41 |
| TOTAL | $-192,286 |
| Total Liabilities And Equity | $74,579 |